Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?
Painful chemotherapy-induced peripheral neuropathy: lack of treatment efficacy or the wrong clinical trial methodology?
复制标题
DOI:
10.1097/j.pain.0000000000000653
复制
发表时间:
2017-01
期刊:
影响因子:
7.4
通讯作者:
Mohile NA
中科院分区:
文献类型:
--
作者:
Gewandter JS;Dworkin RH;Finnerup NB;Mohile NA
1. Primary objectivesTo evaluate the analgesic effects of a treatment on painful chemotherapy-induced peripheral neuropathy (CIPN), pain must be evaluated separately from the other symptoms associated with neuropathy. The primary outcome measures used in the published CIPN trials often assessed general neuropathy symptoms in the same measure, rather than pain alone. The composite measures used in these trials included numeric rating scales (NRS) or visual analogue scales of some combination of pain, numbness, or tingling; the Eastern Cooperative Oncology Group neuropathy scale 14; the National Cancer Institute-Common Toxicity Criteria 20; and the sensory subscale of the European Organization for Research and Treatment of Cancer Quality of Life–Chemotherapy-induced peripheral neuropathy-20. 15
登录
查看更多内容
影响因子:
3.1
作者:
Majithia, Neil;Temkin, Sarah M.;Ruddy, Kathryn J.;Beutler, Andreas S.;Hershman, Dawn L.;Loprinzi, Charles L.
通讯作者:
Loprinzi, Charles L.
影响因子:
3.1
作者:
Gewandter, Jennifer S.;Mohile, Supriya G.;Heckler, Charles E.;Ryan, Julie L.;Kirshner, Jeffrey J.;Flynn, Patrick J.;Hopkins, Judith O.;Morrow, Gary R.
通讯作者:
Morrow, Gary R.
DOI:
10.1111/j.1525-1438.2003.13603.x
发表时间:
2003-11-01
影响因子:
4.8
作者:
Calhoun, EA;Welshman, EE;Cella, D
通讯作者:
Cella, D
影响因子:
6.2
作者:
Rao, Ravi D.;Michalak, John C.;Wong, Gilbert Y.
通讯作者:
Wong, Gilbert Y.
影响因子:
7.4
作者:
Finnerup, Nanna Brix;Sindrup, Soren Hein;Jensen, Troels Staehelin
通讯作者:
Jensen, Troels Staehelin